Geneial Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Geneial General Information
Description
Developer of a rare disease registry platform designed to support patient data collection and research collaboration. The company's platform features registry creation tools, eConsent management, REDCap integration, analytics dashboards, mobile applications, and participant engagement initiatives, enabling advocacy groups and researchers to manage compliant rare disease data collection and research initiatives.
Contact Information
Website
www.geneial.comCorporate Office
- 2762 Parker Oak Pass
- Missouri City, TX 77459
- United States
Corporate Office
- 2762 Parker Oak Pass
- Missouri City, TX 77459
- United States
Geneial Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Aug-2026 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-May-2023 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 30-Mar-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 3. Grant | 22-Sep-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jun-2021 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2021 | $3K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Geneial Patents
Geneial Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023069467-A1 | Privacy-preserving data aggregation and sharing system | Inactive | 19-Oct-2021 | ||
| EP-4315129-A1 | Hardware-accelerated homomorphic encryption in marketplace platforms | Pending | 27-Mar-2021 | ||
| EP-4315129-A4 | Hardware-accelerated homomorphic encryption in marketplace platforms | Pending | 27-Mar-2021 | ||
| US-20240160771-A1 | Hardware-accelerated homomorphic encryption in marketplace platforms | Pending | 27-Mar-2021 | ||
| WO-2022213048-A1 | Hardware-accelerated homomorphic encryption in marketplace platforms | Inactive | 27-Mar-2021 | G06F21/72 |
Geneial Signals
Geneial Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hill Capital Corporation | Growth/Expansion | Minority | ||
| MatchPlay Ventures | Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| Creative Destruction Lab | Accelerator/Incubator | |||
| The National Human Genome Research Institute | Government |
Geneial FAQs
-
When was Geneial founded?
Geneial was founded in 2020.
-
Where is Geneial headquartered?
Geneial is headquartered in Missouri City, TX.
-
What is the size of Geneial?
Geneial has 5 total employees.
-
What industry is Geneial in?
Geneial’s primary industry is Other Healthcare Technology Systems.
-
Is Geneial a private or public company?
Geneial is a Private company.
-
What is Geneial’s current revenue?
The current revenue for Geneial is .
-
Who are Geneial’s investors?
Hill Capital Corporation, MatchPlay Ventures, National Institutes of Health, Creative Destruction Lab, and The National Human Genome Research Institute are 5 of 7 investors who have invested in Geneial.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process